MK0518 in the Treatment of HIV-Infected Patients Switched From a Protease Inhibitor Regimen (0518-033)(TERMINATED)
Status:
Terminated
Trial end date:
2009-04-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the efficacy, safety, and tolerability of an
investigational treatment for patients with Human Immunodeficiency Virus (HIV).